Concizumab reduces bleeding episodes in hemophilia patients with inhibitors
1. In this phase three open-label randomized trial, concizumab prophylaxis reduced the annualized bleeding rate in patients with hemophilia with ...
Tag: Concizumab
#VisualAbstract: Phase 3 Trial of Concizumab in Hemophilia with Inhibitors
Click to view this study in NEJM. ©2023 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced ...